A derivation leads to a proposal for a further volume-based parameter, which is total lesion glycolysis divided by patient weight. Determining whether the use of TLG/W in the NSCLC patient series of Hyun et al. increases the significance level of their results, would help to assess the clinical prognosis interest of this alternative dimensionless volume-based parameter.